載入...
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma
BACKGROUND. Biomarkers can improve clinical trial efficiency, but designing and interpreting biomarker-driven trials require knowledge of relationships among biomarkers, clinical covariates, and endpoints. We investigated these relationships across genomic subgroups of glioblastoma (GBM) within our...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570228/ https://ncbi.nlm.nih.gov/pubmed/28339723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now312 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|